John Oyler, a biotech CEO, reached a $1 billion net worth, earning himself a spot on the list.
Mr. Oyler is the CEO and co-founder of BeiGene, which was founded in Beijing in 2010. He owns 6 percent of the company.
Mr. Oyler also started and sold two companies before BeiGene, including telecom research firm Telephia and drug outsourcing company BioDuro, which he sold for $77 million in 2010.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
